The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
From Nanotechnology to Nanomedicine: Applications to Cancer Research
Open accessAbstract
Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Todays analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice. Keywords: Nanomedicine, circulating tumour cell, nanoparticle, EPR effect, Nanotechnology, Enzymes, Antibodies, Blood-brain barrier, Nano-objects, Nanospheres, Nanotubes, Nanorods, Nanowires, Biosensors, Biomolecules, Biomarkers, Metastases, Clonogenic cancer cells, Epithelial Cell Adhesion Molecule, EpCAM(CD326), Antigen, Antibody, immunohistochemistry, Fluorescence microscope, CTC chip, Aptamers, Aptasensors, Nanovectorization, Surface plasmon resonance, Ellipsometry, SPR imaging, Microfluidics, Microtechnologies, Electrophoresis, ELISA, Labs-on-chip, Point-of-care devices, Drug delivery, Radiotherapy, Chemotherapy, Pharmacokinetics, Reticuloendothelial system, Immune system, Nanoparticles, Vectorization, Doxorubicin, Anthracyclins, Cardiotoxicity, Myelosuppression, Paclitaxel, Docetaxel, DNA topoisomerase, XMT-1001, Camptothecin, Tumor necrosis, Factor alpha, Reactive oxygen species
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
Discher, D. E., Janmey, P., & Wang, Y.-L. (2005) · Science · doi:10.1126/science.1116995 · Cited by 6,382
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 2×
“Taking advantage of this EPR effect [108, 111, 112, 116] (see Fig.”
BackgroundRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Cited by
Foulkes, R., Man, E., Thind, J., Yeung, S., Joy, A., & Hoskins, C. (2020) · Biomaterials Science · doi:10.1039/d0bm00558d · Cited by 568
Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects
Rai, M., Kon, K., Ingle, A., Duran, N., Galdiero, S., & Galdiero, M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5473-x · Cited by 487
Nagajyothi, P. C., Muthuraman, P., Sreekanth, T. V. M., Kim, D. H., & Shim, J. (2017) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2016.01.011 · Cited by 428
Pugazhendhi, A., Prabhu, R., Muruganantham, K., Shanmuganathan, R., & Natarajan, S. (2019) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2018.11.014 · Cited by 418
Prasad, M., Lambe, U. P., Brar, B., Shah, I., J, M., Ranjan, K., Rao, R., Kumar, S., Mahant, S., Khurana, S. K., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.026 · Cited by 327
Metadata
- Authors
- Seigneuric, R., Markey, L., S.A. Nuyten, D., Dubernet, C., T.A. Evelo, C., Finot, E., & Garrido, C.
- Venue
- Current Molecular Medicine
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-10-01
- Volume
- 10
- Issue
- 7
- Pages
- 640-652
- ISSN
- 1566-5240 (ISSN-L)
- OpenAlex
- W2117327657
- Cited by
- 182
- References
- 21
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Nanotechnology to Nanomedicine: Applications to Cancer Research. https://app.cochat.ai/papers/10.2174/156652410792630634
- The paper
- Seigneuric, R., Markey, L., S.A. Nuyten, D., Dubernet, C., T.A. Evelo, C., Finot, E., & Garrido, C. (2010). From Nanotechnology to Nanomedicine: Applications to Cancer Research. Current Molecular Medicine. https://doi.org/10.2174/156652410792630634
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.